QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
LON:KMK

Kromek Group (KMK) Share Forecast, Price & News

GBX 10.75
0.00 (0.00%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
10.51
10.88
50-Day Range
8
12.05
52-Week Range
7.91
21.50
Volume
570,812 shs
Average Volume
1.10 million shs
Market Capitalization
£46.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive KMK News and Ratings via Email

Sign-up to receive the latest news and ratings for Kromek Group and its competitors with MarketBeat's FREE daily newsletter.

Kromek Group logo

About Kromek Group

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear industry, CBRNe security, and safety screening markets in the United Kingdom, North America, Asia, Europe, Australasia, and Africa. The company's products provide high-resolution information on material composition and structure that are used in various applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, as well as the analysis of radioactive materials. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection. In addition, the company provides medical imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT systems. Further, it offers CBRNE homeland security products and solutions for government, border control, airport and seaports, HazMat teams, ambulance crews, police, and armed forces, as well as a range of gamma spectroscopy software that enables specialized gamma-ray spectroscopy for the analysis of samples. Additionally, the company provides CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
152
Year Founded
N/A

Sales & Book Value

Annual Sales
£10.48 million
Cash Flow
GBX 3.19 per share
Book Value
GBX 11.30 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£46.42 million
Optionable
Not Optionable

Company Calendar

Last Earnings
12/11/2019
Today
5/19/2022
Next Earnings (Estimated)
7/12/2022

MarketRank

Overall MarketRank

1.39 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -













Kromek Group (LON:KMK) Frequently Asked Questions

When is Kromek Group's next earnings date?

Kromek Group is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022.
View our earnings forecast for Kromek Group
.

How were Kromek Group's earnings last quarter?

Kromek Group plc (LON:KMK) issued its quarterly earnings data on Wednesday, December, 11th. The company reported ($0.70) EPS for the quarter.
View Kromek Group's earnings history
.

Who are Kromek Group's key executives?
Kromek Group's management team includes the following people:
  • Dr. Arnab Basu MBE, CEO & Exec. Director (Age 49, Pay $231k)
  • Mr. Paul N. Farquhar, CFO, Company Sec. & Director (Age 60, Pay $179k)
  • Mr. Albertus Beumer, COO & Exec. Director
  • Mr. Ian Radley, Chief Technical Officer (Age 65)
  • Prof. Brian Keith Tanner MA, DPhil, CPhys, FInstP, FRSA, Advisor (Age 74)
  • Prof. Max Robinson, Advisor (Age 77)
What other stocks do shareholders of Kromek Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kromek Group investors own include Eden Research (EDEN), Alkemy Capital Investments (ALK), Surgical Innovations Group (SUN), Amigo (AMGO), AMETEK (AME), Amur Minerals (AMC), Aminex (AEX), Aditxt (ADTX), Adamis Pharmaceuticals (ADMP) and Acasti Pharma (ACST).

What is Kromek Group's stock symbol?

Kromek Group trades on the London Stock Exchange (LON) under the ticker symbol "KMK."

How do I buy shares of Kromek Group?

Shares of KMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Kromek Group's stock price today?

One share of KMK stock can currently be purchased for approximately GBX 10.75.

How much money does Kromek Group make?

Kromek Group has a market capitalization of £46.42 million and generates £10.48 million in revenue each year.

How many employees does Kromek Group have?

Kromek Group employs 152 workers across the globe.

What is Kromek Group's official website?

The official website for Kromek Group is www.kromek.com.

How can I contact Kromek Group?

Kromek Group's mailing address is Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom. The company can be reached via phone at +44-1740-626060.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.